Epilepsy is one of the most common chronic neurological disorders and is an important public health problem affecting close to 70 million people worldwide [1]. This number approximates about 0.7% of the global burden of disease and contributes up to 17 million disability adjusted life-years (DALYs) annually [2]. Up to 90% of the people with epilepsy (PWE) reside in low and middle income countries (LMICs) [1], with 20% of the global burden in Africa alone [3]. Another 500 million people are affected indirectly as parents, relatives and friends [4].
9
MAY
MAY
0